Elevated levels of various inflammatory cytokines such as osteoprotegerin, tumor necrosis factor-a, interleukin-6, and C-reactive protein were also reported to be related with worse vascular outcomes in DM patients with LEAD undergoing infrapopliteal endovascular therapy [27]. Here, TNFRSF11B is linked to diabetes mellitus.